Mmv Medicines for Malaria Venture

Mmv Medicines for Malaria Venture is an organisation in Cointrin, Switzerland that has taken part in 8 EU-funded projects since 2009, receiving €77k in EU funding.

EU funding received€77k
EU projects8
As coordinator0
Running now6
First EU project2009
Latest project2026
CountrySwitzerland
EU registration (PIC)996517279
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Mmv Medicines for Malaria Venture's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€59k · 1 project
  • Horizon Europe€19k · 6 projects
  • Horizon 2020€0 · 1 project

Projects

8 EU-funded projects, newest first. Each links to the official record.

  • WANECAM 3Partner

    SINGLE DOSE CURE OF FALCIPARUM MALARIA USING NEXT GENERATION COMBINATIONS

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €19ktheir share
  • CUREMALPartner

    Innovative Transformative CURE for MALaria: Rapid-Action Combinations to Replace Artemisinins

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

  • OPT-MVACAssociated partner

    Optimizing the delivery and uptake of malaria vaccines in countries with areas of highly seasonal transmission in West and Central Africa

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • RAFIKIAssociated partner

    EU-Africa Research Infrastructure Alliance to Foster Infectious Disease research, Knowledge sharing and Innovation

    Horizon Europe · 2025–2027 · Project on CORDIS ↗

  • SAFIREAssociated partner

    SAFETY OF ANTIMALARIALS IN THE FIRST TRIMESTER: AN ADAPTIVE PLATFORM TRIAL

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

  • SEMA ReACTAssociated partner

    SEvere MAlaria treatment with Rectal artesunate and Artemisinin-based Combination Therapy [in remote settings]

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

  • ESCulabPartner

    European Screening Centre; Unique Library for Attractive Biology

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

  • CRIMALDDIPartner

    Coordination, rationalisation and integration of antimalarial drug discovery initiatives

    FP7 (2007 to 2013) · 2009–2011 · Project on CORDIS ↗

    €59ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • business models
  • drug discovery
  • drug resistance
  • innovation management
  • malaria
  • obstetrics
  • pharmacokinetics
  • public health
  • sustainable economy

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime